Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY19 is not expected to be complete until June, 2020.

  1. Novel Trap for Ticks and Fleas Incorporating a CO2 Generator

    SBC: TDA Research, Inc.            Topic: DHP13007

    Military personnel must be protected from diseases transmitted by ticks and fleas, including Lyme disease. Effective surveillance of tick and flea vectors is vital to determine the population present, whether they are carrying disease, and whether control campaigns are working. Unfortunately, current surveillance tools are ineffective. In Phase I TDA designed, prototyped, and tested a novel ti ...

    SBIR Phase II 2015 Department of DefenseDefense Health Program
  2. Novel Vector Survaillance Trap for Flying Insects

    SBC: TDA Research, Inc.            Topic: DHP12007

    Civilian and military organizations throughout the world perform surveillance to combat vector-borne disease. Of particular concern to the U.S. military are mosquito genera Anopheles, Aedes and Culex, which are important vectors for malaria, dengue and West Nile virus respectively, and sand fly genera Phlebotomus and Lutzomyia, both vectors for leishmaniasis. The trap most commonly used for by U.S ...

    SBIR Phase I 2013 Department of DefenseDefense Health Program
  3. Development of a Novel Cryostasis Cocktail for High Subzero Banking of Human Organs

    SBC: Sylvatica Biotech, Inc.            Topic: DHP15013

    The technical objective of this Phase 1 proposal is to develop a non-toxic, multi-component, next generation cryostasis cocktail. We seek to develop a unique, holistic and non-toxic approach to bank human organs for several weeks up to a few months. Our approach is based on using the best strategies employed by freeze-tolerant and hibernating animals in nature and then augmenting them with complem ...

    SBIR Phase I 2015 Department of DefenseDefense Health Program
  4. Cohort Builder for Healthcare Quality Assurance and Comparative Health Effectiveness Research

    SBC: Big Computing, LLC            Topic: DHP12006

    We propose to carry out a three-phase R & D project leading to a scalable, easy-to-use Cohort Builder software tool making it possible for clinical practitioners and quality assurance personnel to carry out comparative health research studies quickly and effectively, without the need for in-depth data or analytics expertise. In Phase I, we will investigate strategic, operational, and technical iss ...

    SBIR Phase I 2013 Department of DefenseDefense Health Program
  5. Novel Rewarming Technique for Cyropreserved Tissue

    SBC: TDA Research, Inc.            Topic: DHP15014

    TDAs proposes to develop a novel RF heating process for rewarming cryogenically preserved tissues and organs. TDAs approach is to optimize the RF frequency and power, along with the chemical composition, size and morphology of infused nanoparticles so that they heat tissue samples rapidly and uniformly. In this manner, the cryoprotectant solutions pass from the vitrified state to the liquid stat ...

    SBIR Phase I 2015 Department of DefenseDefense Health Program
  6. Responsive Sequestration Coating

    SBC: TDA Research, Inc.            Topic: CBD13101

    TDA Research, Inc. and the University of Colorado at Boulder will team together to develop a responsive sequestration coating for chemical warfare agents. The coating will be easily applied to surfaces where it will cover and contain chemical warfare agents on vehicles or other hardware known or suspected to be contaminated. A color change of the coating will indicate locations of underlying surf ...

    SBIR Phase I 2013 Department of DefenseOffice for Chemical and Biological Defense
  7. ARCH Technology for a Simple, Resilient, and Cost-Effective Auto- Injector

    SBC: AKTIVAX, INC.            Topic: CBD13106

    A prefilled auto-injector device for storing a beneficial agent in a dry and stable format alongside a diluent, and automatically delivering the beneficial agent to a patient after reconstitution. The device comprises an automatic needle insertion mechanism and automatic needle retraction mechanism and is safe and disabled after use. The primary drug container of the auto-injector is made from ...

    SBIR Phase I 2013 Department of DefenseOffice for Chemical and Biological Defense
US Flag An Official Website of the United States Government